id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-0329-0008,FDA,FDA-2014-D-0329,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Fees for Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and Cosmetic Act",Notice,30 Day Proposed Information Collection,2017-10-16T04:00:00Z,2017,10,2017-10-16T04:00:00Z,2017-11-16T04:59:59Z,2017-11-14T02:03:22Z,2017-22283,0,0,0900006482bcde53
FDA-2014-D-0329-0007,FDA,FDA-2014-D-0329,"Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Fees for Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and Cosmetic Act",Notice,60 Day Proposed Information Collection,2017-06-15T04:00:00Z,2017,6,2017-06-15T04:00:00Z,2017-08-15T03:59:59Z,2017-06-15T14:09:31Z,2017-12353,0,0,09000064826dbc34